Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 340

1.

The use of passive visual stimuli to enhance compliance with handwashing in a perioperative setting.

Beyfus TA, Dawson NL, Danner CH, Rawal B, Gruber PE, Petrou SP.

Am J Infect Control. 2016 Jan 29. pii: S0196-6553(15)01291-2. doi: 10.1016/j.ajic.2015.12.021. [Epub ahead of print]

PMID:
26831276
2.

Psychometric properties of Patient Reported Outcome Measures (PROMs) in patients diagnosed with Acute Respiratory Distress Syndrome (ARDS).

Shah HA, Dritsaki M, Pink J, Petrou S.

Health Qual Life Outcomes. 2016 Jan 27;14(1):15. doi: 10.1186/s12955-016-0417-7.

3.

Reply.

Thiel DD, Davidiuk AJ, Meschia C, Serie D, Custer K, Petrou SP, Parker AS.

Urology. 2016 Jan 18. pii: S0090-4295(15)01154-1. doi: 10.1016/j.urology.2015.10.039. [Epub ahead of print] No abstract available.

PMID:
26797576
4.

Mayo Adhesive Probability Score Is Associated With Localized Renal Cell Carcinoma Progression-free Survival.

Thiel DD, Davidiuk AJ, Meschia C, Serie D, Custer K, Petrou SP, Parker AS.

Urology. 2015 Dec 23. pii: S0090-4295(15)01136-X. doi: 10.1016/j.urology.2015.10.034. [Epub ahead of print]

PMID:
26723183
5.

Facet-joint injections for people with persistent non-specific low back pain (FIS): study protocol for a randomised controlled feasibility trial.

Sandhu H, Ellard DR, Achana F, Antrobus JH, Balasubramanian S, Brown S, Cairns M, Griffiths F, Haywood K, Hutchinson C, Lall R, Petrou S, Stallard N, Tysall C, Walsh DA, Underwood M.

Trials. 2015 Dec 24;16(1):588. doi: 10.1186/s13063-015-1117-z.

6.

Loss of synaptic Zn(2+) transporter function increases risk of febrile seizures.

Hildebrand MS, Phillips AM, Mullen SA, Adlard PA, Hardies K, Damiano JA, Wimmer V, Bellows ST, McMahon JM, Burgess R, Hendrickx R, Weckhuysen S, Suls A, De Jonghe P, Scheffer IE, Petrou S, Berkovic SF, Reid CA.

Sci Rep. 2015 Dec 9;5:17816. doi: 10.1038/srep17816.

7.

Urologic-Induced Complications of Prophylactic Ureteral Localization Stent Placement for Colorectal Surgery Cases.

Pathak RA, Taylor AS, Alford S, Broderick GA, Igel TC, Petrou SP, Wehle MJ, Young PR, Thiel DD.

J Laparoendosc Adv Surg Tech A. 2015 Dec;25(12):966-70. doi: 10.1089/lap.2015.0345. Epub 2015 Nov 19.

PMID:
26583763
8.

Salvage autologous fascial sling after failed synthetic midurethral sling: Greater than 3-year outcomes.

Petrou SP, Davidiuk AJ, Rawal B, Arnold M, Thiel DD.

Int J Urol. 2015 Nov 13. doi: 10.1111/iju.13003. [Epub ahead of print]

PMID:
26563492
9.

The Maps Reporting Statement for Studies Mapping onto Generic Preference-Based outcome Measures.

Petrou S, Rivero-Arias O, Dakin H, Longworth L, Oppe M, Froud R, Gray A.

Value Health. 2015 Nov;18(7):A715-6. doi: 10.1016/j.jval.2015.09.2702. Epub 2015 Oct 20. No abstract available.

PMID:
26534007
10.
12.

Quinidine in the treatment of KCNT1-positive epilepsies.

Mikati MA, Jiang YH, Carboni M, Shashi V, Petrovski S, Spillmann R, Milligan CJ, Li M, Grefe A, McConkie A, Berkovic S, Scheffer I, Mullen S, Bonner M, Petrou S, Goldstein D.

Ann Neurol. 2015 Dec;78(6):995-9. doi: 10.1002/ana.24520. Epub 2015 Nov 18.

PMID:
26369628
13.

PRIMA1 mutation: a new cause of nocturnal frontal lobe epilepsy.

Hildebrand MS, Tankard R, Gazina EV, Damiano JA, Lawrence KM, Dahl HH, Regan BM, Shearer AE, Smith RJ, Marini C, Guerrini R, Labate A, Gambardella A, Tinuper P, Lichetta L, Baldassari S, Bisulli F, Pippucci T, Scheffer IE, Reid CA, Petrou S, Bahlo M, Berkovic SF.

Ann Clin Transl Neurol. 2015 Aug;2(8):821-30. doi: 10.1002/acn3.224. Epub 2015 Jul 3.

14.

Generation of Local CA1 γ Oscillations by Tetanic Stimulation.

Hatch RJ, Reid CA, Petrou S.

J Vis Exp. 2015 Aug 14;(102):e52877. doi: 10.3791/52877.

PMID:
26327580
15.

Preferred reporting items for studies mapping onto preference-based outcome measures: The MAPS statement.

Petrou S, Rivero-Arias O, Dakin H, Longworth L, Oppe M, Froud R, Gray A.

J Med Econ. 2015 Nov;18(11):851-7. doi: 10.3111/13696998.2015.1070554. Epub 2015 Jul 30.

PMID:
26295698
16.

PREFERRED REPORTING ITEMS FOR STUDIES MAPPING ONTO PREFERENCE-BASED OUTCOME MEASURES: THE MAPS STATEMENT.

Petrou S, Rivero-Arias O, Dakin H, Longworth L, Oppe M, Froud R, Gray A.

Int J Technol Assess Health Care. 2015 Jan;31(4):230-5. doi: 10.1017/S0266462315000379. Epub 2015 Aug 3.

17.

Preferred reporting items for studies mapping onto preference-based outcome measures: The MAPS statement.

Petrou S, Rivero-Arias O, Dakin H, Longworth L, Oppe M, Froud R, Gray A.

Health Qual Life Outcomes. 2015 Aug 1;13:106. doi: 10.1186/s12955-015-0305-6.

18.

Preferred Reporting Items for Studies Mapping onto Preference-Based Outcome Measures: The MAPS Statement.

Petrou S, Rivero-Arias O, Dakin H, Longworth L, Oppe M, Froud R, Gray A.

Pharmacoeconomics. 2015 Oct;33(10):985-91. doi: 10.1007/s40273-015-0319-2.

19.

The MAPS Reporting Statement for Studies Mapping onto Generic Preference-Based Outcome Measures: Explanation and Elaboration.

Petrou S, Rivero-Arias O, Dakin H, Longworth L, Oppe M, Froud R, Gray A.

Pharmacoeconomics. 2015 Oct;33(10):993-1011. doi: 10.1007/s40273-015-0312-9.

PMID:
26232200
20.

Preferred Reporting Items for Studies Mapping onto Preference-Based Outcome Measures: The MAPS Statement.

Petrou S, Rivero-Arias O, Dakin H, Longworth L, Oppe M, Froud R, Gray A.

Appl Health Econ Health Policy. 2015 Oct;13(5):437-43. doi: 10.1007/s40258-015-0191-4.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk